CorMedix Inc.

CRMD XNAS • PHARMACEUTICAL PREPARATIONS

Historical Short Interest Share

Chase Ink Business Preferred®

Earn Up to 150K Bonus Points

Transfer points to 14+ airline & hotel partners. Up to 40% upgrade value on first class travel. $95/yr.

Apply Now

Market Cap

620M

Short interest (Jul 15)

19.6%

Net Short (Jul 27 ): 0.2%

Borrow Fee

0.69%

↓ 10.6%

Available Shares

↑ 191.2%

Price Chart

Company Overview

Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.

Company Info

Exchange: NASDAQ

Industry: PHARMACEUTICAL PREPARATIONS

CIK: 0001410098

Asset Type: CS

Market Data

Market Cap: $617,416,382

Employees: 191

Status: Active

Short Interest

Current Borrow Fee 0.69%

Range: 0.69% - 0.69%

Available Shares 1M

Range: 600K - 1.8M

Recent Changes

Fee Change: ↑ 0.4%

Available Change: ↓ 29.4%

Quick Actions

View Dilution Chart

Add to Watchlist Set Price Alert View Options Chain

Investment Risk

This is not financial advice. All investments carry risk. Do your own research before making investment decisions.

Weekly Research

Get Weekly Super Stonk Alerts

Never miss a squeeze opportunity. Get our weekly analysis of high short interest stocks, AI-discovered gems, and dilution warnings delivered to your inbox.

No spam • Unsubscribe anytime